85.13MMarket Cap
LossP/E TTM
Champions Oncology Inc's Company Valuation
Currency: USD Updated: 2026-07-24The current valuation score of Champions Oncology Inc is 8.93, ranking 78 out of 386 in the Biotechnology & Medical Research industry. Its current P/E ratio is -35.53, which is -2383.51% below the recent high of 811.43 and -644.93% above the recent low of -264.71.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.